Kwality Pharmaceuticals Reports 38.95% YoY Revenue Growth in Q3FY24

Kwality Pharmaceuticals Limited has announced its unaudited financial results for the quarter and nine months ended 31st December, 2023. The company's consolidated revenue increased by 38.95% YoY and 12.13% QoQ to Rs 78.1 cr in Q3FY24, driven by expansion into new geographies and new product approvals. EBITDA margins improved slightly to 22.16%, and net profit stood at Rs 7.67 cr, up 24% sequentially. Management believes that the company is on the verge of reporting improved performance, driven by new product approvals and facility upgrades. The company aims to double its revenue by FY26 compared to FY23 sales of around Rs 251 cr, with sustainable EBITDA margins of 22-25%.,